Welcome: Guest | Site Use Options | Register | Login |

Balance Therapeutics Inc

Balance Therapeutics Inc

Profile last edited on: 6/9/2016
1250 Bayhill Drive Unit 125
San Bruno, CA 94066
  (650) 741-9100
Business Identifier: Drug therapies for intellectual disability: Down's syndrome and Alzheimers disease.
Public Profile:
Balance Therapeutics, spun out of Stanford, is a R&D company focused on developing therapeutics to address conditions of intellectual disability to include Down syndrome and Alzheimers disease. The firm's pharmacological approach is based on technology licensed from Stanford University that has demonstrated promising potential to address cognitive deficits in animal models of Down syndrome and Alzheimers disease. Focused on the development of BTD-001 DS102, a placebo-controlled molecule product that can be administered orally for young adults and adolescents with Down syndrome, clinical trials are currently in progress for Down Syndrome. The firm has a wholly owned subsidiary in Melbourne, Australia.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Translating Innovative Research Discoveries to a Potential Therapeutic for Down S

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920